NCT07173998 Quality of Life in Patients With Postoperative Atrial Fibrillation After Cardiac Surgery
| NCT ID | NCT07173998 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Brigham and Women's Hospital |
| Condition | Postoperative Atrial Fibrillation |
| Study Type | OBSERVATIONAL |
| Enrollment | 260 participants |
| Start Date | 2025-07-15 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 260 participants in total. It began in 2025-07-15 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Prospective observational study on quality of life with postoperative atrial fibrillation after cardiac surgery using SF-36 and qualitative questions
Eligibility Criteria
Inclusion Criteria: * All genders * Ages 18-99 years old * Scheduled to undergo cardiac surgery * Able to answer survey questions Exclusion Criteria: * Persistent / permanent atrial fibrillation * Atrial fibrillation at presentation for surgery * Emergent operations
Contact & Investigator
Jakob Wollborn, MD, MPH
PRINCIPAL INVESTIGATOR
Brigham and Women's Hospital
Frequently Asked Questions
Who can join the NCT07173998 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 100 Years, studying Postoperative Atrial Fibrillation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07173998 currently recruiting?
Yes, NCT07173998 is actively recruiting participants. Contact the research team at lsimeth@bwh.harvard.edu for enrollment information.
Where is the NCT07173998 trial being conducted?
This trial is being conducted at Boston, United States.
Who is sponsoring the NCT07173998 clinical trial?
NCT07173998 is sponsored by Brigham and Women's Hospital. The principal investigator is Jakob Wollborn, MD, MPH at Brigham and Women's Hospital. The trial plans to enroll 260 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.